A new biomarker derived from the Framingham Heart Study measures the speed of biological decline, offering a more sensitive endpoint for anti-aging clinical trials. A rate-based biomarker from the Fra...
Analyzing recent rapamycin clinical trials for anti-aging, focusing on optimal dosing, safety, and the shift from off-label use to evidence-based protocols in longevity research. New human trials on r...